DK1706452T3 - Aromatiske triamid-lanthanidkomplekser - Google Patents

Aromatiske triamid-lanthanidkomplekser

Info

Publication number
DK1706452T3
DK1706452T3 DK04822131T DK04822131T DK1706452T3 DK 1706452 T3 DK1706452 T3 DK 1706452T3 DK 04822131 T DK04822131 T DK 04822131T DK 04822131 T DK04822131 T DK 04822131T DK 1706452 T3 DK1706452 T3 DK 1706452T3
Authority
DK
Denmark
Prior art keywords
ligands
lanthanide complexes
triamide
aromatic
phthalamidyl
Prior art date
Application number
DK04822131T
Other languages
English (en)
Inventor
Kenneth N Raymond
Stephane Petoud
Jide Xu
Original Assignee
Univ California Office Of The
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ California Office Of The filed Critical Univ California Office Of The
Application granted granted Critical
Publication of DK1706452T3 publication Critical patent/DK1706452T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/42—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/44—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring
    • C07C235/58—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring with carbon atoms of carboxamide groups and singly-bound oxygen atoms, bound in ortho-position to carbon atoms of the same non-condensed six-membered aromatic ring
    • C07C235/60—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring with carbon atoms of carboxamide groups and singly-bound oxygen atoms, bound in ortho-position to carbon atoms of the same non-condensed six-membered aromatic ring having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06—Esters of carbamic acids
    • C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C271/20—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by nitrogen atoms not being part of nitro or nitroso groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/08—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D277/12—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/16—Sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • C12Q1/37—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving peptidase or proteinase
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531—Production of immunochemical test materials
    • G01N33/532—Production of labelled immunochemicals
    • G01N33/533—Production of labelled immunochemicals with fluorescent label
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/536—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
    • G01N33/542—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with steric inhibition or signal modification, e.g. fluorescent quenching
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/582—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with fluorescent label
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/11—Compounds covalently bound to a solid support

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Fats And Perfumes (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK04822131T 2003-12-30 2004-12-29 Aromatiske triamid-lanthanidkomplekser DK1706452T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US53348203P 2003-12-30 2003-12-30
PCT/US2004/043968 WO2006001835A2 (en) 2003-12-30 2004-12-29 Aromatic triamide-lanthanide complexes

Publications (1)

Publication Number Publication Date
DK1706452T3 true DK1706452T3 (da) 2009-01-19

Family

ID=35782206

Family Applications (1)

Application Number Title Priority Date Filing Date
DK04822131T DK1706452T3 (da) 2003-12-30 2004-12-29 Aromatiske triamid-lanthanidkomplekser

Country Status (7)

Country Link
US (1) US8551453B2 (da)
EP (1) EP1706452B1 (da)
AT (1) ATE407176T1 (da)
CA (1) CA2552537A1 (da)
DE (1) DE602004016390D1 (da)
DK (1) DK1706452T3 (da)
WO (1) WO2006001835A2 (da)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000048990A1 (en) * 1999-02-18 2000-08-24 The Regents Of The University Of California Phthalamide-lanthanide complexes for use as luminescent markers
AU2007272604B2 (en) 2006-07-10 2013-08-01 The Regents Of The University Of California Luminescent 1-hydroxy-2-pyridinone chelates of lanthanides
CA2660800C (en) * 2006-08-15 2016-03-01 The Regents Of The University Of California Luminescent macrocyclic lanthanide complexes
US8507199B2 (en) * 2007-01-25 2013-08-13 Lumiphore, Inc. Multi-color time resolved fluorophores based on macrocyclic lanthanide complexes
WO2010051544A2 (en) * 2008-10-31 2010-05-06 Lumiphore, Inc. Rapid homogeneous diagnostic testing platform based on lanthanide fluorescent resonance energy transfer
WO2011006011A2 (en) * 2009-07-08 2011-01-13 Virginia Tech Intellectual Properties Inc. Theranostic polycation beacons comprising oligoethyleneamine repeating units and lanthanide chelates
EP2470513B1 (en) 2009-08-24 2014-10-08 Lumiphore, Inc. Macrocyclic hopo chelators
JP2013515744A (ja) * 2009-12-24 2013-05-09 ルミフォア，インコーポレイテッド 放射性医薬品錯体
WO2011146775A1 (en) * 2010-05-19 2011-11-24 Dionex Corporation Functionalized substrates with aromatic stacking properties
CN102766041B (zh) * 2012-08-17 2015-01-28 济南大学 一种水杨醛衍生物中间体的制备方法
US11453652B2 (en) 2013-03-15 2022-09-27 Lumiphore, Inc. Di-macrocycles
EP3041853B1 (en) 2013-09-06 2021-08-11 The Regents of The University of Michigan Metallacrown complexes and methods of making the same
EP3297637B1 (en) * 2015-05-21 2021-05-26 Ohio State Innovation Foundation Benzene-1,3,5-tricarboxamide derivatives and uses thereof
ES2859775T3 (es) 2018-07-05 2021-10-04 Univ Strasbourg Nanopartículas de lantánido luminiscentes ultrabrillantes que comprenden terbio, con una mayor vida útil de estado excitado
CN116806830A (zh) * 2022-09-14 2023-09-29 江苏省农业科学院 一种溶杆菌来源嗜铁素的应用

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL98864C (da) * 1956-10-02
US4748184A (en) * 1982-07-26 1988-05-31 E. I. Du Pont De Nemours And Company Aryl substituted aminomethyl benzene derivatives having antiarrhythmic utility
US4855225A (en) 1986-02-07 1989-08-08 Applied Biosystems, Inc. Method of detecting electrophoretically separated oligonucleotides
US5047519A (en) 1986-07-02 1991-09-10 E. I. Du Pont De Nemours And Company Alkynylamino-nucleotides
SE8801702D0 (sv) 1988-05-05 1988-05-05 Pharmacia Ab Sett vid bestemning av enzymatisk aktivitet
WO1989011475A1 (en) 1988-05-25 1989-11-30 The United States Of America, As Represented By Th Macrocyclic chelates and methods of use thereof
US5049280A (en) 1989-03-29 1991-09-17 The Regents Of The University Of California 2,3-dihydroxyterephthalamides as highly effective metal ion sequestering compounds
WO1992011039A1 (en) 1990-12-17 1992-07-09 The United States Of America, As Represented By The Secretary, U.S. Department Of Commerce Derivatized tris-catechol chelating agents
DE4222255A1 (de) 1992-07-07 1994-01-13 Bayer Ag Fotochemische Markierung von Nukleinsäuren mit Europiumchelat-Reagenzien und ihre Verwendung in Gensondentestsystemen
TW275070B (da) 1992-12-22 1996-05-01 Ciba Geigy Ag
DE19525924A1 (de) 1995-07-04 1997-01-09 Schering Ag Kaskaden-Polymer-Komplexe, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Mittel
SE506700C2 (sv) 1996-05-31 1998-02-02 Mikael Kubista Sond och förfaranden för analys av nukleinsyra
US5989823A (en) 1998-09-18 1999-11-23 Nexstar Pharmaceuticals, Inc. Homogeneous detection of a target through nucleic acid ligand-ligand beacon interaction
JPH11352623A (ja) * 1998-06-10 1999-12-24 Konica Corp 熱現像感光材料およびその包装方法
WO2000048990A1 (en) 1999-02-18 2000-08-24 The Regents Of The University Of California Phthalamide-lanthanide complexes for use as luminescent markers
WO2000048991A1 (en) 1999-02-18 2000-08-24 The Regents Of The University Of California Salicylamide-lanthanide complexes for use as luminescent markers
JP4112908B2 (ja) * 2002-06-07 2008-07-02 株式会社日立プラントテクノロジー 連続攪拌装置及び重縮合系樹脂の連続重縮合方法
US7018852B2 (en) * 2002-08-01 2006-03-28 D-Wave Systems, Inc. Methods for single qubit gate teleportation
CA2660800C (en) 2006-08-15 2016-03-01 The Regents Of The University Of California Luminescent macrocyclic lanthanide complexes
US8507199B2 (en) 2007-01-25 2013-08-13 Lumiphore, Inc. Multi-color time resolved fluorophores based on macrocyclic lanthanide complexes
WO2010051544A2 (en) 2008-10-31 2010-05-06 Lumiphore, Inc. Rapid homogeneous diagnostic testing platform based on lanthanide fluorescent resonance energy transfer

Also Published As

Publication number Publication date
DE602004016390D1 (en) 2008-10-16
ATE407176T1 (de) 2008-09-15
US8551453B2 (en) 2013-10-08
EP1706452A2 (en) 2006-10-04
WO2006001835A2 (en) 2006-01-05
WO2006001835A3 (en) 2006-04-06
US20090036537A1 (en) 2009-02-05
EP1706452A4 (en) 2007-01-10
CA2552537A1 (en) 2006-01-05
EP1706452B1 (en) 2008-09-03

Similar Documents

Publication Publication Date Title
DK1154991T3 (da) Salicylamid-lanthanidkomplekser til anvendelse som luminescerende markörer
DE60016898D1 (de) Phthalamid-lanthanid komplexe zur verwendung als lumineszenzmarker
DK1706452T3 (da) Aromatiske triamid-lanthanidkomplekser
MXPA03006055A (es) Nuevos compuestos de n-fenilpirrolbisfosfano y sus complejos de metal.
TW200634128A (en) Polymer compound and elements using the same
CY1105386T1 (el) Βενζοϋλοσουλφοναμιδια και σουλφονυλβενζαμιδινες για χρηση σαν παραγοντες κατα του ογκου
TW200615277A (en) Metal complexes
DE60138597D1 (de) Lumineszente Vorrichtung und dafür verwendete Metallkoordinationsverbindung
NO20041123L (no) Biodegraderbare chelatsammensetninger for fraktureringsfluider.
IL158865A0 (en) Luminescent lanthanide complexes with imine ligands and devices made with such complexes
DE50214578D1 (de) Gehäuse für einen elektronischen schlüssel
DE69807558D1 (de) Chelatkomplexe paramagnetischer Metalle mit niedriger Toxizität
ATE225178T1 (de) Chelate und metalchelate zur behandlung von durch freie radikale verursachte zustände
TW200602076A (en) O, O'-amidomalonate and N, O-amidomalonate platinum complexes
ATE446349T1 (de) Luminescente polymere
WO2005001415A3 (en) Optically pure and enriched isomers of chelating ligands and contrast agents
HRPK20030734B3 (en) A combination comprising combretastatin and anticancer agents
DE60018390D1 (de) Chelatierende verbindungen, ihre komplexe mit paramagnetischen metallen
MX2008002233A (es) Ligandos para iones de metal y metodos para elaborar y usar los mismos.
HRP20030576B1 (en) Lithium complexes of n-(1-hydroxymethyl-2,3-dihydroxypropyl)-1,4,7-triscarboxymethyl-1,4,7,10-tetraazacyclododecane, production and use thereof
ATE339790T1 (de) Bausatz für eine steckvorrichtungs-kombination
WO2004033423A3 (en) Anticancer compounds
DE602004002277D1 (de) Filter enthaltend ein metallphthalocyanin und ein polykationisches polymer
ATE167477T1 (de) Makrozyclische chelante, ihre chelate und verwendungen in diagnostik
LT2003075A (en) Inhibitor of monoamine uptake